Ani pharmaceuticals announces the launch of pentoxifylline extended-release tablets, usp

Baudette, minn., jan. 23, 2024 (globe newswire) -- ani pharmaceuticals, inc. (ani or the company) (nasdaq: anip) today announced the launch of pentoxifylline extended-release (er) tablets, usp 400mg.

ANIP Ratings Summary

ANIP Quant Ranking